Track the 올리패스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 올리패스 has logged 97 public disclosures. The latest transaction was disclosed on 15 December 2025 (Purchase). Among the most active insiders: 제노큐어. Every trade is free.
97
Insider Decl.
n/a
Thresholds
n/a
83 ops.
Buy Volume
n/a
1 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
OliPass es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo de tratamientos innovadores y soluciones terapéuticas.